Point72 Middle East FZE’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,855
Closed -$1.89K 2006
2023
Q2
$1.89K Buy
+3,855
New +$3.15K ﹤0.01% 1465
2023
Q1
Sell
-7,029
Closed -$18.8K 2359
2022
Q4
$18.8K Buy
+7,029
New +$18.5K ﹤0.01% 1646

Other funds holding CELL

Point72 Middle East FZE's CELL Position: Q3 2023 in Review

Point72 Middle East FZE sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 3,855 shares — an estimated $1.89K sold.

Point72 Middle East FZE first reported a position in CELL in Q4 2022 and held it in 2 quarters. The position peaked at $18.8K in Q4 2022. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Point72 Middle East FZE reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 3,855 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $1.89K.
  • Point72 Middle East FZE first reported a position in PhenomeX Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's PhenomeX Inc. Common Stock position peaked at $18.8K in Q4 2022.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.